Deep vein thrombosis: 2016 recommendations of the American College of Chest Physicians
| Deep vein thrombosis or pulmonary embolism without cancer |
| For the initial 3 months, a direct oral anticoagulant (dabigatran, rivaroxaban, apixaban edoxaban) is preferable to a vitamin K antagonist (grade 2B) |
| If a direct oral anticoagulant is not used, a vitamin K antagonist is preferable to low-molecular-weight heparin (grade 2B) |
| Deep vein thrombosis or pulmonary embolism with cancer |
| Low-molecular-weight heparin is preferable to a vitamin K antagonist or direct oral anticoagulant (grade 2C) |
Based on information in reference 1.